2021 NLCRT Annual Meeting
2021 NLCRT Annual Meeting
December 6-7, 2021
Disparities to Equity: Moving the Needle on Lung Cancer
Each year, the NLCRT membership, a nationwide coalition of over 160 professional and national societies, cancer centers, government agencies, research groups, advocacy and policy organizations, and corporate associates convenes to work together on our shared goal to create lung cancer survivors.
The 2021 virtual conference featured the work of those who are shaping a more equitable direction to lung cancer care and control in areas such as risk reduction, early detection, tobacco prevention and treatment, diagnosis and therapy, survivorship, and policy. The overarching goal of the conference was to address the determinants of minority health and cancer-related health disparities to advance health equity across the lung cancer continuum.
The conference highlighted keynote presentations and conversations led by Monica Webb Hooper, PhD, Deputy Director of the National Institute on Minority Health and Health Disparities, and Robert A. Winn, MD, Director of the Massey Cancer Center at Virginia Commonwealth University. In addition, the NLCRT showcased its strategic priority committees’ work and its initiatives that focused on eliminating lung cancer stigma, promoting lung cancer screening implementation, uptake, and adherence, and optimizing lung cancer biomarkers in practice.
Through the NLCRT, we are working to ensure that no one is disadvantaged in their fight against lung cancer because of their socioeconomic status, their race or ethnicity, their sexual orientation, their gender identity, their disability status, their insurance status, or where they live.
We thank all of NLCRT organizational members and non-members along with advocates, survivors, and caregivers for attending the 5th Annual Meeting.
Not currently a member? Learn more about NLCRT membership.
See the 2021 Meeting Executive Summary
Day 1 Keynote Speaker
Monica Webb Hooper, PhD
Deputy Director of the National Institute on Minority Health and Health Disparities, National Institutes of Health
Monica Webb Hooper, PhD, is a leader in minority health and cancer-related health disparities research. Her work spans multiple disparity populations, including African Americans, Hispanics/Latinos, persons of lower socioeconomic privilege, and people living with HIV/AIDS.
Day 2 Keynote Speaker
Robert A. Winn, MD
Director and Lipman Chair in Oncology
VCU Massey Cancer Center
Robert A. Winn, MD, is the director of the VCU Massey Cancer Center, a cancer center designated by the National Cancer Institute that provides advanced cancer care, conducts groundbreaking research to discover new therapies for cancer, offers high-quality education and training, and engages with the community to make advancements in cancer treatment and prevention equally available to all.
Agenda
See the presentation slides (if they are available) by clicking on the links in the table.[vc_tta_tabs]Session Descriptions & Recordings10:00am – 10:15am ET
WELCOME TO THE NLCRT ANNUAL MEETING AND OPENING SESSION
Welcome and Opening Remarks
Ella Kazerooni, MD, MS, FACR, FSABI, NLCRT Chair, University of Michigan
Patient Advocate Story
Ida Pittman, Helena Price, and Cherie P. Erkmen, MD, Temple University Hospital10:15am – 11:45pm ET
SESSION TWO: KEYNOTE ADDRESS & MODERATED EXPERT PANEL
Deconstructing Disparities to Prevent and Cure Lung Cancer
Keynote Speaker
Monica Webb Hooper, PhD, National Institute on Minority Health and Health Disparities
Panelists
Jill Feldman, EGFR Resisters
Louis A. Penner, PhD, FSESP, Karmanos Cancer Institute
David T. Cooke, MD, FACS, University of California, Davis Medical Center
John P. Williams, MD, FACS, President’s Cancer Panel
Moderator
M. Patricia Rivera, MD, ATSF, FCCP, University North Carolina at Chapel Hill2:15pmBreak12:20pm – 1:40pm ET
SESSION THREE: RAPID-FIRE PRESENTATIONS
Examining Disparities and Equity in Lung Cancer Across the Care Continuum
Part 1: Promoting Equity Through Reaching Diverse and Vulnerable Populations
Moderator
Leah M. Backhus, MD, MPH, FACS, Standford University
Presentations
Lung Cancer is Just Different: Understanding the Population is the First Step in Reducing Disparities. Gerard A. Silvestri, MD, MS, FCCP, Medical University of South Carolina
Understanding the Hispanic Health Paradox in the Context of Lung Cancer. Heidi A. Hamann, PhD, University of Arizona
Geographic Access to Lung Cancer Screening Among Eligible Adults Living in Rural and Urban Environments in the US. Liora Sahar, PhD, GISP, Grace GIS
Feasibility and Acceptability of a Collaborative Lung Cancer Screening Educational Intervention Tailored for Individuals with Serious Mental Illness. Kelly E. Irwin, MD, MPH, Massachusetts General Hospital
Community Engagement Towards Increasing Lung Cancer Screening. Alexandra Potter, American Lung Cancer Screening Initiative
Studying Trial Determinants of Success (STRIDES): Understanding Barriers and Facilitators to Clinical Trial Accrual Among Patients with Lung Cancer in the Deep South. Andrew Ciupek, PhD, GO2 Foundation for Lung Cancer
ACR Lung Cancer Screening Improvement Collaborative. Neville Irani, MD, University of Kansas Medical Center
Kentucky Health Collaborative: Lung Cancer Screening, Detection, and Treatment Initiative. Timothy W. Mullett, MD, MBA, FACS, University of Kentucky
ScreenNJ: A Statewide Prevention and Screening Program. Anita Y. Kinney, PhD, RN, FAAN, FABMR, Rutgers Cancer Institute of New Jersey1:45pm – 3:05pm ET
Part 2: Innovation and Advancement in the Lung Cancer Field
Moderator
Juan P. Wisnivesky, MD, DrPH, Mount Sinai Health System
Presentations
Advancing Payment Models Towards Lung Cancer Screening Uptake. A. Mark Fendrick, MD, University of Michigan
Harnessing the EMR: Lung Cancer Screening Shared Decision-Making Tool Integration into EPIC. Tanner Caverly, MD, MPH, University of Michigan; Kensaku Kawamoto, MD, PhD, MHS, FACMI, FAMIA, University of Utah
Department of Veterans Affairs Lung Precision Oncology Program. Christopher G. Slatore, MD, MS, Oregon Health & Science University
Molecular Screening and Early Diagnosis of Cancer. Sana Raoof, MD, PhD, Memorial Sloan Kettering Cancer Center
Barriers to Equitable Biomarker Testing in Underserved Patients with NSCLC. Leigh M. Boehmer, PharmD, BCOP, Association of Community Cancer Centers
Small Cell Lung Cancer Initiative. Jennifer C. King, PhD, GO2 Foundation for Lung Cancer
Palliative Care Interventions as Optimal Lung Cancer Care. Jennifer S. Temel, MD, Massachusetts General Hospital
Looking Through the Equity Lens: Vulnerable Populations with Lung Cancer. Narjust Duma, MD, Dana-Farber Cancer Institute3:05pm – 3:15pm ETCLOSING REMARKS and END OF DAY 1
Ella Kazerooni, MD, MS, FACR, FSABI, NLCRT Chair, University of MichiganSession Descriptions & Recordings10:00am – 10:40am ET
SESSION FOUR: WELCOME TO DAY 2 OF THE NLCRT ANNUAL MEETING
Welcome and Opening Remarks
Douglas E. Wood, MD, FACS, NLCRT Vice-Chair, University of Washington
Patient Advocate Story (Video)
Heidi N. Onda, The White Ribbon Project
Pierre T. Onda, MD, The White Ribbon Project
NLCRT Remembrance of Pierre P. Massion, MD
Jennifer A. Lewis, MD, MS, MPH, Vanderbilt University Medical Center
Gerard A. Silvestri, MD, MS, FCCP, Medical University of South Carolina11:00am – 12:40 pm ET
SESSION FIVE: KEYNOTE ADDRESS AND MODERATED EXPERT PANEL
Building Equitable Lung Cancer Control and Care for All
Keynote Speaker
Robert A. Winn, MD, Massey Cancer Center at Virginia Commonwealth University
Panelists
Brandi Bryant, Team Draft
Manali I. Patel, MD, MPH, MS, Stanford University
Marshall H. Chin, MD, MPH, FACP, University of Chicago
Nicole Richie, PhD, Genentech
Moderator
Gerard A. Silvestri, MD, MS, FCCP, Medical University of South Carolina1:05am – 2:30 pm ET
SESSION SIX: NLCRT HIGHLIGHTS – PRIORITY INITIATIVES
Moderator
Farhood Farjah, MD, MPH, FACS, University of Washington
Campaign to End Lung Cancer Stigma – A National Initiative
Overview of Campaign, Summit, and Future. Lisa M. Carter, PhD, APRN, ANP-C, FAAN, Memorial Sloan Kettering Cancer Center
Lung Cancer Stigma and the Veterans Community. James Pantelas, Veterans Health Administration
IASLC Language Guide. Kristin Ito, International Association for the Study of Lung Cancer
Empathic Communications Skills Training. Jamie S. Ostroff, PhD, Memorial Sloan Kettering Cancer Center
Lung Cancer Stigma Health System Assessment Guide. Jamie L. Studts, PhD, University of Colorado
Optimizing Lung Cancer Biomarkers in Practice – A National Initiative
Biomarker Testing Guidelines Consensus Panel. M. Patricia Rivera, MD, ATSF, FCCP, University of North Carolina at Chapel Hill
Biomarker Testing Playbook. Bruce E. Johnson, MD, FASCO, Dana-Farber Cancer Institute
Biomarker Testing Turnaround Time. Ignacio I. Wistuba, MD, MD Anderson Cancer Center
Addressing Comprehensive Lung Cancer Biomarker Testing Through Project ECHO. Raymond U. Osarogiagbon, MBBS, FACP, Baptist Cancer Center2:45pm – 4:05pm ET
SESSION SEVEN: NLCRT HIGHLIGHTS – PRIORITY PROJECTS
Moderator
Joelle T. Fathi, DNP, RN, ARNP, CTTS, FAAN, University of Washington
Presentations
State-Based Lung Cancer Coalition-Building Guide. Jessica E. Olson, PhD, MPH, Medical College of Wisconsin
LungPLAN: Projecting Lung Assessment Needs. Carey C. Thomson, MD, MPH, ATSF, Mt. Auburn Hospital/Beth Israel Lahey Health
Multimodal Intervention Strategies to Improve Lung Cancer Screening for Women Undergoing Breast Screening. Kim L. Sandler, MD, Vanderbilt University Medical Center
Partnership with American Academy of Family Physicians. Robert J. Volk, PhD, MD Anderson Cancer Center
Lung Cancer Screening Webinar & Podcast Series for the Lung Cancer Community. Efren J. Flores, MD, Massachusetts General Hospital4:05pm – 4:15pm ETCLOSING REMARKS AND END OF ANNUAL MEETING
Ella Kazerooni, MD, MS, FACR, FSABI, NLCRT Chair, University of Michigan
Douglas Wood, MD, FACS, FRCSEd, NLCRT Vice-Chair, University of Washington[/vc_tta_tabs]